U.S. markets closed
  • S&P Futures

    3,980.50
    +10.25 (+0.26%)
     
  • Dow Futures

    33,917.00
    +46.00 (+0.14%)
     
  • Nasdaq Futures

    11,658.50
    +42.25 (+0.36%)
     
  • Russell 2000 Futures

    1,840.60
    +7.80 (+0.43%)
     
  • Crude Oil

    78.06
    +0.82 (+1.06%)
     
  • Gold

    1,748.60
    +8.30 (+0.48%)
     
  • Silver

    21.20
    +0.29 (+1.39%)
     
  • EUR/USD

    1.0380
    +0.0035 (+0.34%)
     
  • 10-Yr Bond

    3.7030
    +0.0120 (+0.33%)
     
  • Vix

    22.21
    +1.71 (+8.34%)
     
  • GBP/USD

    1.2007
    +0.0042 (+0.35%)
     
  • USD/JPY

    138.5500
    -0.3510 (-0.25%)
     
  • BTC-USD

    16,278.65
    +110.38 (+0.68%)
     
  • CMC Crypto 200

    383.37
    +3.08 (+0.81%)
     
  • FTSE 100

    7,474.02
    -12.65 (-0.17%)
     
  • Nikkei 225

    27,999.82
    -163.01 (-0.58%)
     

Why Moderna Stock Lagged the Market Today

Why Moderna Stock Lagged the Market Today

This was the case with high-profile biotech Moderna (NASDAQ: MRNA) on Wednesday. Moderna's positive news came from across the Atlantic Ocean, where the European Medicines Agency (EMA) accepted a conditional marketing authorization (CMA) application for the company's bivalent coronavirus booster vaccine. Moderna didn't hesitate to point out that the new booster has already been given the green light by the U.S. Food and Drug Administration (FDA) and a host of other jurisdictions, including Australia, Taiwan, and the U.K.